Brazilian Health Biotechnology Innovation System: an essay about the public policy rationale
DOI:
https://doi.org/10.21664/2238-8869.2016v5i1.p14-30Abstract
The emergence of biotechnology is one of the most important changes in the health innovation systems. This paper discusses the rationale that has supported the public policies oriented to boost health biotechnology development in Brazil during 2004 and 2014. Based on a thorough revision of policy documents and on an extensive fieldwork, the study highlights the accumulative path followed by the Brazilian public policies. This research shows how these policies followed an uneven accumulative path were several rationales cohabited integrating explicit and implicit policies. Finally, the boundaries of policy action are discussed, stressing two critical dimensions that delimit the scope of policy action: i) the change of policy orientation and rationale, ii) that pose new governance’s challenges, which, in turn require new coordination with other implicit policies.Downloads
Published
2016-06-28
How to Cite
BIANCHI, Carlos. Brazilian Health Biotechnology Innovation System: an essay about the public policy rationale. Fronteiras - Journal of Social, Technological and Environmental Science, [S. l.], v. 5, n. 1, p. 14–30, 2016. DOI: 10.21664/2238-8869.2016v5i1.p14-30. Disponível em: https://periodicos.unievangelica.edu.br/index.php/fronteiras/article/view/1619. Acesso em: 22 dec. 2024.
Issue
Section
Dossier –Biotechnology and Innovation: from Research and Teaching Laboratories to Public Politics
License
This journal offers immediate free access to its content, following the principle that providing free scientific knowledge to the public, we provides greater global democratization of knowledge.
As of the publication in the journal the authors have copyright and publication rights of their articles without restrictions.
The Revista Fronteiras: Journal of Social, Technological and Environmental Science follows the legal precepts of the Creative Commons - Attribution-NonCommercial-ShareAlike 4.0 International.